Cytiva’s first acquisition since being acquired by Danaher sees it add robotic aseptic filling machines to its bioprocess offering. Vanrx Pharmasystems, and all 120 staff, will be incorporated into Cytiva, after the bioprocess vendor acquired the Canadian company for an undisclosed fee. Vanrx makes standardized aseptic filling technologies for filling vials, syringes, and cartridges, including its SA25 range of aseptic and lyophilized technologies, and the Microcell Vial Filler – a closed robotic isolator for pharmaceutical vial filling. “For now, this…

Gamma Biosciences’ bioseparation business Astrea will use the Affimer technology to expand its range of ligand discovery and development capabilities. Avacta Group’s Affimer reagents are small proteins that have a binding surface that can be tailored to capture a target molecule of interest out of complex mixtures encountered in biomanufacturing. “The Affimer reagent technology was originally developed at the MRC Cancer Unit in Cambridge UK for proteomics applications and was acquired by Avacta in 2012,” Alastair Smith, CEO of Avacta…

Sartorius Stedim Biotech says it continues to take on the challenges in efficient downstream processing through the proposed addition of Novasep’s chromatography equipment business. The deal, set to go through in the next few months, will see Sartorius bolster its downstream offering within its Stedim Biotech bioprocessing division. Financial terms have not been disclosed for now, and the acquisition is dependent on antitrust approvals. “The unit to acquire comprises resin-based batch and intensified chromatography systems, and primarily focuses on high-pressure,…